After Hours Summary: ALT falls -10.5% after FDA issues clinical hold on AdCOVID; MIC jumps +4.1% after declaring one-time dividend of $11/shAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance: None
Companies trading higher in after hours in reaction to news: FFHL +8.7% (gets bid to sell its Dornier production line), HCAP +7.7% (PTMN to merge with HCAP), MIC +4.1% (declares one-time dividend of $11 per share), AFYA +2.1% (approves share buyback program), CLDR +2% (closes on $500 mln debt issuance and the repurchase of Intel's stake in the co for $314 mln), ACI +1.9% (administers first doses of vaccine and is preparing for high consumer demand, hiring pharmacy staff), MGI +1.3% (issues statement on lawsuit filed by SEC against Ripple Labs; says it has not been made aware of any negative impact to its commercial agreement with Ripple), DM +1.2% (stock offering), BUD +1.2% (APO to acquire 49.9% stake in BUD's US-based metal container plants for $3 bln), PTMN +1.1% (PTMN to merge with HCAP), FSP +1% (announces sale of property in Durham, NC), TFC +0.9% (authorizes $2 bln stock repurchase plan following Fed stress test, will maintain dividend), DS +0.7% (files for $500 mln mixed securities shelf offering), EPZM +0.2% (Boehringer Ingelheim terminates collaboration with Epizyme), X +0.2% (sells Keystone Industrial Port Complex for $160 mln), PFE +0.1% (awarded a $2.01 bln US Army contract for the production of vaccine BNT162b2), BHVN +0.1% (stock offering)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: None
Companies trading lower in after hours in reaction to news: ALT -10.5% (FDA has issued a clinical hold on its IND application for AdCOVID), DRTT -4.8% (files for $100 mln mixed securities shelf offering), VRCA -3.8% (resubmits NDA for VP-102 for the treatment of molluscum), AFMD -3.3% (files for $225 mln mixed securities shelf offering), BLU -2.9% (stock offering), TXG -1.1% (to Present at JP Morgan Healthcare Conference), TRQ -1% (evaluating tax assessment from the Mongolian Tax Authority), MRNA -0.8% (co expects its vaccine will protect against new UK Covid variant, according to CNBC tweet), UROV -0.4% (FDA approves NDA for GEMTESA), SHO -0.1% (completes a series of balance sheet enhancing transactions), TAC -0.1% (announces 6% increase to dividend, and announces sale of assets to TransAlta Renewables)
Closing Stock Market SummaryThe stock market rehashed the recovery theme for most of Wednesday's session in which value, cyclical, and small-cap stocks outperformed, but the market finished near session lows as sellers rushed for the exit before the close on no specific news. The S&P 500 finished with a 0.1% gain after being up as much as 0.7% intraday.
The Russell 2000 (+0.9%) and Dow Jones Industrial Average (+0.4%) outperformed with the small-cap index closing above the 2000 level for the first time. The Nasdaq Composite (-0.3%) struggled all session amid relative weakness in growth stocks, which generally underperform when recovery stocks are in favor.
The recovery trade was fueled by President Trump's insistence that Congress increase the stimulus checks to $2000 from $600, which House Democrats supported, and Pfizer (PFE 37.44, +0.70, +1.9%) and BioNTech (BNTX 100.06, -0.50, -0.5%) reaching a second agreement with the U.S. government to supply an additional 100 million doses of their COVID-19 vaccine.
The S&P 500 energy (+2.2%) and financials (+1.6%) sectors accumulated most of the gains amid higher oil prices ($48.09/bbl, +1.09, +2.3%) and curve-steepening activity caused by selling in longer-dated Treasuries. Both developments signaled an improved sentiment regarding future economic growth.
The 2-yr yield increased one basis point to 0.13%, and the 10-yr yield increased four basis points to 0.96%. The U.S. Dollar Index decreased 0.4% to 90.34 amid relative strength in the British pound, which rose 1.0% against the dollar amid reports that an outline of a Brexit trade deal with the EU was reached.
Unfortunately, the top-weighted information technology sector (-0.9%) limited the upside in the market, as buyers preferred to focus away from the growth stocks that comprise the technology space. The real estate (-1.0%) and utilities (-0.2%) sectors slipped into negative territory during the afternoon.
An awareness that many European markets, including Germany, will be closed tomorrow for Christmas Eve, and that the U.S. market will close early at 1:00 p.m. ET, might have exacerbated selling interest into the close. Some investors prefer to be cautious heading into extended holiday breaks.
Separately, homebuilding stocks lagged after data showed the pace of new home sales decline 11.0% m/m to a seasonally adjusted annual rate of 841,000 ( consensus 990,000). The iShares U.S. Home Construction ETF (ITB 57.07, -0.83, -1.4%) decreased 1.4%.
Reviewing all of Wednesday's economic data dump:
- Personal income declined 1.1% m/m in November (consensus -0.2%), personal spending declined 0.4% (consensus -0.2%), the PCE Price Index was unchanged (consensus +0.2%) and the Core PCE Price Index was unchanged (consensus +0.2%).
- The key takeaway for the market isn't that the income and spending data were disappointing, it's that the totality of the disappointment will reassure the market that the Fed is going to remain its friend by sticking with extraordinarily accommodative monetary policy.
- Initial claims for the week ending December 19 decreased by 89,000 to 803,000 (consensus 860,000). Continuing claims for the week ending December 12 decreased by 170,000 to 5.337 million.
- The key takeaway from the report is the week-over-week improvement in both initial claims and continuing claims. Both are still way too high in the big picture, yet the trend is the market's trading friend today.
- New home sales decreased 11.0% m/m to 841,000 in November (consensus 990,000) from a downwardly revised 945,000 (from 999,000) in October. On a yr/yr basis, new home sales were up 20.8%.
- The key takeaway from the report is that new home sales, which are counted when contracts are signed, slowed in November from a torrid recovery pace. Limited supply and rising prices had some impact, yet the strength of the market continues to be evident in the 20.8% increase in sales yr/yr.
- New orders for durable goods increased 0.9% m/m in November (consensus 0.7%) while new orders, excluding transportation, increased 0.4% (consensus 0.5%).
- The key takeaway for the market is that there were order increases across most categories and that business spending stayed on a positive track, evidenced by the 0.4% increase in new orders for nondefense capital goods excluding aircraft.
- The final reading for the December University of Michigan Index of Consumer Sentiment was revised down to 80.7 from the preliminary reading of 81.4. The final reading marks an improvement from the final reading of 76.9 for November.
- The key takeaway from the report is that consumer sentiment was improved from November, notwithstanding the reports of rising coronavirus infections and deaths, as well as the stimulus uncertainty, that prevailed during the survey period.
- The FHFA Housing Price Index for December increased 1.5% following an unrevised 1.7% increase in November.
- The weekly MBA Mortgage Applications Index increased 0.8% following a 1.1% increase in the prior week.
Investors will not receive any economic data on Thursday, which will be a shortened trading session for Christmas Eve.
- Nasdaq Composite +42.3% YTD
- Russell 2000 +20.3% YTD
- S&P 500 +14.2% YTD
- Dow Jones Industrial Average +5.6% YTD